OS Therapies OSTX Chief Operating Decision Maker — Net Income Loss

Similar metrics at other companies

SOTKOperating — Net Income Loss

$340K+24.1%

FHBCorporate And Other Nonoperating — Net Income Loss

-$23.67M+18.2%

ODYSCorporate — Net Income Loss

-$5.18M-21.5%

RUMSingle Operating — Net Income Loss

-$30.27M-1,042%

FCCOCorporate — Net Income Loss

$1.54M+112%

CODACorporate — Net Income Loss

-$574.26K+4.0%

Questions, answered.

What is OS Therapies's chief operating decision maker — net income loss?

OS Therapies (OSTX) reported chief operating decision maker — net income loss of -$10.4M in Q1 2026.

How has OS Therapies's chief operating decision maker — net income loss changed year-over-year?

OS Therapies's chief operating decision maker — net income loss decreased by 168.2% year-over-year, from -$3.88M to -$10.4M.

What does chief operating decision maker — net income loss mean?

Represents the final bottom-line financial result for the primary operating segment after all revenues, expenses, and non-operating items are accounted for. This metric indicates the overall financial health and sustainability of the business segment. For clinical-stage companies, this typically reflects the net cash burn required to advance the drug pipeline.